Simultaneous spectrophotometric eco-friendly analysis of triple-drug H.pylori regimen (Vonoprazan, Amoxicillin, Metronidazole) for quality control and in vitro dissolution testing. [PDF]
Hamdy AM +3 more
europepmc +1 more source
Acid peptic disorder compass: An Indian expert consensus on comprehensive management. [PDF]
Sinha SK +14 more
europepmc +1 more source
Vonoprazan-Containing Triple Therapy Based on Clarithromycin Susceptibility May Be Definitive Treatment Strategy for Eradication of <i>Helicobacter pylori</i>. [PDF]
Murata M +14 more
europepmc +1 more source
Vonoprazan-amoxicillin dual, rifabutin-based triple, and bismuth quadruple therapies for <i>Helicobacter pylori</i> rescue treatment: a multicentre, open-label, non-inferiority randomised trial. [PDF]
Huang Y +10 more
europepmc +1 more source
Fluorescent Yellow Urine Induced by Vonoprazan Fumarate: A Case Report of a Benign Phenomenon. [PDF]
Sheng L, Li X.
europepmc +1 more source
Comment #2 on "First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin" [PDF]
Astegiano, Marco +1 more
core +1 more source
Severe hypomagnesemia and secondary hypocalcemia associated with vonoprazan in a patient with type 2 diabetes. [PDF]
Aotani R +4 more
europepmc +1 more source
A Review on the Progress and Strategies of <i>Helicobacter pylori</i> Eradication Therapy for Patients With Penicillin Allergy. [PDF]
Zhang Y +10 more
europepmc +1 more source
Vonoprazan: MarKed Competition for PPIs? [PDF]
David R, Scott +2 more
openaire +2 more sources

